JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
JMP Securities Starts Clipper Realty Inc. (CLPR) at Market Outperform Citing Discount to NAV
-
JMP Securities Downgrades Gigamon (GIMO) to Market Perform (Friday)
-
ERYTECH Files Registration Statement for Proposed Initial Public Offering in the United States
-
iCIMS Named to Hot 100 List by JMP Securities
-
JMP Securities Starts Cogentix Medical (CGNT) at Market Outperform
-
Zogenix Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Acadia Pharma (ACAD): Raising PT On HARMONY Breakthrough Designation - JMP
-
Cybereason's CISO Israel Barak to Deliver Keynote Address at Infosecurity North America Conference
-
Intrexon (XON) Bullish View Reiterated at JMP Following Positive Regulatory Update for Oxitec
-
PICO Holdings (PICO) Reports Sale of 2.4M Share Stake in Century Communities Inc. (CCS) at $24.67/Sh
-
PICO Holdings, Inc. Announces Sale of Its Stake in Century Communities, Inc.
-
JMP Securities Downgrades Intercept Pharmaceuticals (ICPT) to Market Perform
-
JMP Securities Starts NorthStar Realty Europe Corp. (NRE) at Market Outperform
-
Myovant Sciences Ltd. (MYOV) PT Raised to $25 at JMP Securities
-
Deciphera Pharmaceuticals Announces Closing of Initial Public Offering and Exercise of Option to Purchase Additional Shares
-
Zogenix (ZGNX) Prices 6.7M Share Common Offering at $37.50/Sh
-
JMP Securities Upgrades Acuity Brands (AYI) to Market Perform
-
Zogenix Prices Public Offering of Common Stock
-
Arbutus Biopharma (ABUS) PT Raised to $13 at JMP Securities
-
Cloudera Announces Closing of Follow-on Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
-
Zogenix (ZGNX) to Offer 4.3M Shares
-
Zogenix Announces Proposed Public Offering of 4,300,000 Shares of Common Stock
-
PICO Holdings (PICO) Reports Exploration of Strategic Alternatives Including Possible Sale
-
PICO Holdings Inc. Announces Exploration of Strategic Alternatives Including Possible Sale of the Company
-
JMP Securities Starts Criteo S.A. (CRTO) at Market Outperform
-
JMP Securities Starts The Trade Desk (TTD) at Market Outperform
-
CoStar Group, Inc. Announces Exercise of Underwriters' Option to Purchase an Additional 432,692 Shares of Common Stock
-
Costar Group (CSGP) Prices 2.88M Share Common Offering at $260/Sh
-
CoStar Group, Inc. Announces Pricing of Common Stock Offering
-
Advanced Accelerator Applications (AAAP)/Novartis Deal Would Make Sense, But Timing is a Potential Obstacle; Worth $100+ in Takeover - JMP
-
Deciphera Pharmaceuticals (DCPH) IPO Opens Up 18%
-
Western Asset Mortgage Capital Corporation Announces Pricing Of $100,000,000 Of Convertible Senior Notes Due 2022
-
Cloudera, Inc. (CLDR) Prices 13.4M Share Follow-On Offering at $16.45/Sh; 3M Shares from Cloudera, 10.4M Shares from Selling Stockholders
-
Deciphera Pharmaceuticals Inc. (DCPH) Prices 7.5M Share IPO at $17/Sh
-
JMP Securities Upgrades Syros Pharmaceuticals (SYRS) to Market Outperform
-
Cloudera Announces Pricing of Follow-on Offering
-
Deciphera Pharmaceuticals Announces Pricing of Initial Public Offering
-
Western Asset Mortgage Capital (WMC) Reports $100M Proposed Public Offering Of Convertible Senior Notes Due 2022
-
Western Asset Mortgage Capital Corporation Announces Proposed Public Offering Of Convertible Senior Notes Due 2022
-
Neovasc (NVCN) Has a Working Transfemoral Delivery System Prototype - JMP
-
Twilio (TWLO): Amazon Seesaws Twilio - JMP
-
Ubiquiti Networks (UBNT) Distribution Model Challenges Remain Concerning - JMP Securities
-
Engagio Launches ‘Dash Account Based Attribution’ to Help Marketers Measure and Understand the Impact of ABM Initiatives
-
Axovant Sciences (AXON) PT Lowered to $19 at JMP Securities
-
ProQR Therapeutics N.V. (PRQR) PT Raised to $20 at JMP Securities
-
Cloudera, Inc. (CLDR) Reports 12M Common Stock Offering, Including 9M for Selling Stockholders
-
Cloudera Announces Launch of Proposed Follow-on Offering
-
Intercept Pharmaceuticals (ICPT) PT Lowered to $140 at JMP Securities; Sees Minimal to Modest Sales Impact
-
Neovasc (NVCN) Court Documents Suggest a Major Catalyst is Forthcoming, Possibly a Sale - JMP Securities
-
First Solar (FSLR) to Benefit from Section 201 Injury Finding; PT Trimmed to $65 - JMP Securities

